Toll like receptor 4 in atherosclerosis and plaque destabilization - PubMed (original) (raw)
Review
Toll like receptor 4 in atherosclerosis and plaque destabilization
Wijnand K den Dekker et al. Atherosclerosis. 2010 Apr.
Abstract
The immune system plays a pivotal role in initiation and progression of atherosclerosis. Monocytes and T-lymphocytes are the first cells to enter the damaged endothelium. Differentiation of monocytes into macrophages and ingestion of lipids by these macrophages turning them into foam cells is a crucial step in the development of a fatty streak, the first sign of atherosclerosis. In recent years there has been accumulating evidence for the involvement of Toll like receptor 4, a pattern recognition receptor of the innate immune system, in the pathogenesis of atherosclerosis. Different cell types present in the atherosclerotic plaque express TLR4 and several pro-atherogenic ligands have been shown to activate TLR4. The innate immune system and the TLR signaling cascade may play an important role not only in the pathogenesis of atherosclerosis, but also in plaque destabilization. In this review, we discuss the role of TLR4 in the pathogenesis of atherosclerosis and vulnerable plaque development.
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
Sikorski K, Czerwoniec A, Bujnicki JM, Wesoly J, Bluyssen HA. Sikorski K, et al. Cytokine Growth Factor Rev. 2011 Aug;22(4):211-9. doi: 10.1016/j.cytogfr.2011.06.003. Epub 2011 Jul 12. Cytokine Growth Factor Rev. 2011. PMID: 21752694 Review. - Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells.
Howell KW, Meng X, Fullerton DA, Jin C, Reece TB, Cleveland JC Jr. Howell KW, et al. J Surg Res. 2011 Nov;171(1):e27-31. doi: 10.1016/j.jss.2011.06.033. Epub 2011 Jul 19. J Surg Res. 2011. PMID: 21920554 - Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.
Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G. Schoneveld AH, et al. Atherosclerosis. 2008 Mar;197(1):95-104. doi: 10.1016/j.atherosclerosis.2007.08.004. Epub 2007 Sep 21. Atherosclerosis. 2008. PMID: 17888930 - Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque.
Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Niessner A, et al. Circulation. 2007 Oct 30;116(18):2043-52. doi: 10.1161/CIRCULATIONAHA.107.697789. Epub 2007 Oct 15. Circulation. 2007. PMID: 17938289 - Multiple roles of Toll-like receptor signaling in atherosclerosis.
Björkbacka H. Björkbacka H. Curr Opin Lipidol. 2006 Oct;17(5):527-33. doi: 10.1097/01.mol.0000245258.25387.ec. Curr Opin Lipidol. 2006. PMID: 16960501 Review.
Cited by
- Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Brandão SCS, Ramos JOX, Dompieri LT, Godoi ETAM, Figueiredo JL, Sarinho ESC, Chelvanambi S, Aikawa M. Brandão SCS, et al. Cytokine Growth Factor Rev. 2021 Apr;58:102-110. doi: 10.1016/j.cytogfr.2020.09.002. Epub 2020 Sep 21. Cytokine Growth Factor Rev. 2021. PMID: 32988728 Free PMC article. Review. - Curcumin affects ox-LDL-induced IL-6, TNF-α, MCP-1 secretion and cholesterol efflux in THP-1 cells by suppressing the TLR4/NF-κB/miR33a signaling pathway.
Zhong Y, Liu C, Feng J, Li JF, Fan ZC. Zhong Y, et al. Exp Ther Med. 2020 Sep;20(3):1856-1870. doi: 10.3892/etm.2020.8915. Epub 2020 Jun 19. Exp Ther Med. 2020. PMID: 32782494 Free PMC article. - Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily.
Ferrao R, Li J, Bergamin E, Wu H. Ferrao R, et al. Sci Signal. 2012 May 29;5(226):re3. doi: 10.1126/scisignal.2003124. Sci Signal. 2012. PMID: 22649099 Free PMC article. Review. - miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease.
Feng J, Li A, Deng J, Yang Y, Dang L, Ye Y, Li Y, Zhang W. Feng J, et al. Lipids Health Dis. 2014 Feb 7;13:27. doi: 10.1186/1476-511X-13-27. Lipids Health Dis. 2014. PMID: 24502419 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical